Table 1.
Characteristics | Proportion (%) | |
---|---|---|
|
||
Non-small cell lung cancer | Small cell lung cancer | |
Overall, n (%) | 36,417 (86.0) | 5906 (14.0) |
AJCC-TNM Stagea | ||
I | 20.6 | 5.1 |
II | 4.7 | 2.2 |
III | 28.4 | 29.8 |
IV | 46.2 | 62.9 |
Age (years)a | ||
66–69 | 19.2 | 24 |
70–74 | 25.8 | 28.8 |
75–79 | 25.9 | 26.2 |
≥80 | 29.1 | 21 |
Gendera | ||
Male | 51.9 | 47.4 |
Female | 48.1 | 52.6 |
Racea | ||
Non-white | 13.3 | 9.2 |
White | 86.7 | 90.8 |
Urban–rural residencea | ||
Metro | 83.1 | 80.2 |
Urban | 14.9 | 17.2 |
Rural | 2 | 2.6 |
Comorbidity, Charlson scorea | ||
0 | 31.7 | 29.7 |
1 | 28.5 | 28.8 |
≥2 | 39.8 | 41.5 |
AJCC = American Joint Committee on Cancer; TNM = Tumor Node Metastasis.
Association between characteristic and cancer type among beneficiaries; Chi-square tests (p ≤ 0.05).